Coronary thrombolysis and the new biology
- 1 October 1989
- journal article
- clinical trial
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 14 (4) , 850-860
- https://doi.org/10.1016/0735-1097(89)90455-5
Abstract
No abstract availableThis publication has 43 references indexed in Scilit:
- Potential attenuation of fibrinolysis by growth factors released from platelets and their pharmacologic implicationsThe American Journal of Cardiology, 1989
- Comparison of Invasive and Conservative Strategies after Treatment with Intravenous Tissue Plasminogen Activator in Acute Myocardial InfarctionNew England Journal of Medicine, 1989
- A Randomized Trial of Intravenous Tissue Plasminogen Activator for Acute Myocardial Infarction with Subsequent Randomization to Elective Coronary AngioplastyNew England Journal of Medicine, 1987
- A Randomized Trial of Immediate versus Delayed Elective Angioplasty after Intravenous Tissue Plasminogen Activator in Acute Myocardial InfarctionNew England Journal of Medicine, 1987
- The Thrombolysis in Myocardial Infarction (TIMI) TrialNew England Journal of Medicine, 1985
- Thrombolytic therapy in patients with acute myocardial infarction.Circulation, 1985
- Coronary thrombolysis with recombinant human tissue-type plasminogen activator: a prospective, randomized, placebo-controlled trial.Circulation, 1984
- Coronary Thrombolysis with Tissue-Type Plasminogen Activator in Patients with Evolving Myocardial InfarctionNew England Journal of Medicine, 1984
- Coronary thrombolysis with intravenously administered human tissue-type plasminogen activator produced by recombinant DNA technology.Circulation, 1984
- Estimation of Infarct Size in Man and its Relation to PrognosisCirculation, 1972